Cannabis Rescheduling: Page 12

‘There Will Be Wind in Our Sails’

‘Descheduling Would Not Be Utopia’

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

Opinion: HHS Rescheduling Recommendation is 'About Damn Time'

The U.S. Department of Health and Human Services recognition that cannabis should no longer be classified in the same category as heroin is an event to be celebrated. But the trajectory of U.S. policy deserves to be mourned.

'Descheduling Would Not Be Utopia'

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

The Impacts of Cannabis Rescheduling: Panelists Weigh In During International Cannabis Bar Association Webinar

Industry legal experts Khurshid Khoja, Amber Littlejohn and Shane Pennington shared insight into what rescheduling could mean for taxes, research and federal enforcement.

Colorado Governor to President Biden: ‘We Must Do Better’ on Federal Cannabis Reform

Gov. Jared Polis encouraged the president to move swiftly to reschedule cannabis and urged him to not let up on other incremental changes.

‘Rescheduling is Not Enough,’ And Other Reactions to HHS Recommendation on Cannabis

Cannabis industry responds with cautious optimism to the Department of Health and Human Services' call to reschedule the plant, noting the significance of the announcement but also the potential limitations of the move.

US Health and Human Services Department Recommends Cannabis Reclassified to Schedule III

The move from Schedule I to Schedule III would provide that cannabis has a federally accepted medical use, but the decision now goes to the DEA.

New Coalition Launches Campaign in Support of Cannabis Scheduling Reform

As the Biden Administration actively reviews the classification of cannabis under the Controlled Substances Act, a diverse group of cannabis companies and organizations is partnering with scientific and legal experts to launch the Coalition for Cannabis Scheduling Reform.

After Oklahoma, the Cannabis Industry Eagerly Awaits Legalization Action Elsewhere

Attorneys share their reactions to state legislatures considering legalization, what they make of voters rejecting an adult-use market in Oklahoma, and what it all means for federal policy reform.

A Unified National Cannabis Policy

FDA’s new senior public health adviser Norman Birenbaum talks about the agency’s approach to hemp-derived products and cannabis regulation, and what may come next.

US Representative Reintroduces Legislation to Reschedule Cannabis

Rep. Greg Steube has reintroduced the Marijuana 1-to-3 Act, which would reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.

Previous Page

Page 12 of 13

Next Page